carbenoxolone sodium has been researched along with Cerebral Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorrance, AM; Osmond, JM | 1 |
1 other study(ies) available for carbenoxolone sodium and Cerebral Infarction
| Article | Year |
|---|---|
11beta-hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Brain Ischemia; Carbenoxolone; Cerebral Infarction; Cerebrovascular Circulation; Enzyme Inhibitors; Male; Middle Cerebral Artery; Muscle Development; Muscle Tonus; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Serotonin; Vasoconstriction | 2009 |